{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:45Z","timestamp":1786980105426,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Grant Office, Faculty of Medicine, Assiut University, Egypt","award":["(Grant No. 2020-09-22-002-R1)"],"award-info":[{"award-number":["(Grant No. 2020-09-22-002-R1)"]}]},{"name":"the Grant Office, Faculty of Medicine, Assiut University, Egypt","award":["(Grant No. 2020-09-22-002-R1)"],"award-info":[{"award-number":["(Grant No. 2020-09-22-002-R1)"]}]},{"name":"the Grant Office, Faculty of Medicine, Assiut University, Egypt","award":["(Grant No. 2020-09-22-002-R1)"],"award-info":[{"award-number":["(Grant No. 2020-09-22-002-R1)"]}]},{"name":"the Grant Office, Faculty of Medicine, Assiut University, Egypt","award":["(Grant No. 2020-09-22-002-R1)"],"award-info":[{"award-number":["(Grant No. 2020-09-22-002-R1)"]}]},{"name":"the Grant Office, Faculty of Medicine, Assiut University, Egypt","award":["(Grant No. 2020-09-22-002-R1)"],"award-info":[{"award-number":["(Grant No. 2020-09-22-002-R1)"]}]},{"name":"the Grant Office, Faculty of Medicine, Assiut University, Egypt","award":["(Grant No. 2020-09-22-002-R1)"],"award-info":[{"award-number":["(Grant No. 2020-09-22-002-R1)"]}]},{"name":"the Grant Office, Faculty of Medicine, Assiut University, Egypt","award":["(Grant No. 2020-09-22-002-R1)"],"award-info":[{"award-number":["(Grant No. 2020-09-22-002-R1)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04294-9","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T06:38:05Z","timestamp":1748846285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative study of different treatment modalities for melasma: introducing a novel nanotechnology-based tranexamic acid microemulsion"],"prefix":"10.1007","volume":"317","author":[{"given":"Eman R. M.","family":"Hofny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-7129","authenticated-orcid":false,"given":"Ayatollah H.","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia M.","family":"Badary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa G.","family":"Elnaggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin E.","family":"Eleraky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam M.","family":"Abdel-Bary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Y.","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"4","key":"4294_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1080\/09546634.2021.1914313","volume":"33","author":"N Neagu","year":"2022","unstructured":"Neagu N, Conforti C, Agozzino M, Marangi GF, Morariu SH, Pellacani G et al (2022) Melasma treatment: a systematic review. J Dermatolog Treat 33(4):1816\u20131837. https:\/\/doi.org\/10.1080\/09546634.2021.1914313","journal-title":"J Dermatolog Treat"},{"key":"4294_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2147\/CCID.S396272","volume":"16","author":"W Liu","year":"2023","unstructured":"Liu W, Chen Q, Xia Y (2023) New mechanistic insights of melasma. Clin Cosmet Investig Dermatol 16:429\u2013442. https:\/\/doi.org\/10.2147\/CCID.S396272","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"4294_CR3","doi-asserted-by":"publisher","first-page":"713554","DOI":"10.3389\/fmed.2021.713554","volume":"8","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu S, Wu H, Liang X, Guo D, Zhuo F (2021) Comparison of the efficacy of melasma treatments: A network Meta-Analysis of randomized controlled trials. Front Med 8:713554. https:\/\/doi.org\/10.3389\/fmed.2021.713554","journal-title":"Front Med"},{"issue":"8","key":"4294_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamadermatol.2013.4294","volume":"149","author":"AM Ahmed","year":"2013","unstructured":"Ahmed AM, Lopez I, Perese F, Vasquez R, Hynan LS, Chong B et al (2013) A randomized, double-blinded, placebo-controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma. JAMA Dermatol 149(8):981\u2013983. https:\/\/doi.org\/10.1001\/jamadermatol.2013.4294","journal-title":"JAMA Dermatol"},{"issue":"11","key":"4294_CR5","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1111\/jocd.13725","volume":"19","author":"NA Dorgham","year":"2020","unstructured":"Dorgham NA, Hegazy RA, Sharobim AK, Dorgham DA (2020) Efficacy and tolerability of chemical peeling as a single agent for melasma in dark-skinned patients: A systematic review and meta-analysis of comparative trials. J Cosmet Dermatol 19(11):2812\u20132819. https:\/\/doi.org\/10.1111\/jocd.13725","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"4294_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/ijd.15133","volume":"60","author":"KM Babbush","year":"2021","unstructured":"Babbush KM, Babbush RA, Khachemoune A (2021) Treatment of melasma: a review of less commonly used antioxidants. Int J Dermatol 60(2):166\u2013173. https:\/\/doi.org\/10.1111\/ijd.15133","journal-title":"Int J Dermatol"},{"issue":"4","key":"4294_CR7","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/jocd.15589","volume":"22","author":"H Konisky","year":"2023","unstructured":"Konisky H, Balazic E, Jaller JA, Khanna U, Kobets K (2023) Tranexamic acid in melasma: A focused review on drug administration routes. J Cosmet Dermatol 22(4):1197\u20131206. https:\/\/doi.org\/10.1111\/jocd.15589","journal-title":"J Cosmet Dermatol"},{"key":"4294_CR8","doi-asserted-by":"publisher","first-page":"1337282","DOI":"10.3389\/fphar.2024.1337282","volume":"15","author":"P Ghasemiyeh","year":"2024","unstructured":"Ghasemiyeh P, Fazlinejad R, Kiafar MR, Rasekh S, Mokhtarzadegan M, Mohammadi-Samani S (2024) Different therapeutic approaches in melasma: advances and limitations. Front Pharmacol 15:1337282. https:\/\/doi.org\/10.3389\/fphar.2024.1337282","journal-title":"Front Pharmacol"},{"key":"4294_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.34172\/apb.42794","volume":"14","author":"A Kheirieh","year":"2024","unstructured":"Kheirieh A, Kheirieh A, Mahdavi Z et al (2024) Energy-Based methods and Nanocarrier-Based approaches for melasma treatment. Adv Pharm Bull 14:759\u2013793. https:\/\/doi.org\/10.34172\/apb.42794","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"4294_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/lsm.23032","volume":"51","author":"SO Tawfic","year":"2019","unstructured":"Tawfic SO, Abdel Halim DM, Albarbary A, Abdelhady M (2019) Assessment of combined fractional CO2 and Tranexamic acid in melasma treatment. Lasers Surg Med 51(1):27\u201333. https:\/\/doi.org\/10.1002\/lsm.23032","journal-title":"Lasers Surg Med"},{"issue":"3","key":"4294_CR11","doi-asserted-by":"publisher","first-page":"NP181","DOI":"10.1093\/asj\/sjac286","volume":"43","author":"A Muskat","year":"2022","unstructured":"Muskat A, Kost Y, Balazic E, Cohen JL, Kobets K (2022) Laser-Assisted drug delivery in the treatment of scars, rhytids, and melasma: A comprehensive review of the literature. Aesthet Surg J 43(3):NP181\u2013NP98. https:\/\/doi.org\/10.1093\/asj\/sjac286","journal-title":"Aesthet Surg J"},{"issue":"1","key":"4294_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10103-024-03972-w","volume":"39","author":"S Zhao","year":"2024","unstructured":"Zhao S, Wang M, Lai X, Yan Y (2024) Efficacy and safety of ablative fractional laser in melasma: A Meta-analysis and systematic review. Lasers Med Sci 39(1):71. https:\/\/doi.org\/10.1007\/s10103-024-03972-w","journal-title":"Lasers Med Sci"},{"issue":"9","key":"4294_CR13","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s13555-022-00780-4","volume":"12","author":"DP Cassiano","year":"2022","unstructured":"Cassiano DP, Esp\u00f3sito ACC, da Silva CN et al (2022) Update on Melasma\u2014Part II: treatment. Dermatol Ther 12(9):1989\u20132012. https:\/\/doi.org\/10.1007\/s13555-022-00780-4","journal-title":"Dermatol Ther"},{"issue":"4","key":"4294_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/cup.13115","volume":"45","author":"S Muzumdar","year":"2018","unstructured":"Muzumdar S, Argraves M, Kristjansson A, Ferenczi K, Dadras SS (2018) A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun\u2010damaged skin. J Cutan Pathol 45(4):263\u2013268. https:\/\/doi.org\/10.1111\/cup.13115","journal-title":"J Cutan Pathol"},{"issue":"null","key":"4294_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2147\/CCID.S333376","volume":"14","author":"SE Dass","year":"2021","unstructured":"Dass SE, Huizenga T, Farshchian M, Mehregan DR (2021) Comparison of SOX-10, HMB-45, and Melan-A in benign melanocytic lesions. Clin Cosmet Investig Dermatol 14(null):1419\u20131425. https:\/\/doi.org\/10.2147\/CCID.S333376","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"4294_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.21608\/bfsa.2005.65405","volume":"28","author":"M EL-Badry","year":"2005","unstructured":"EL-Badry M, Hussein N (2005) Formulation and evaluation of croconazol hydrochloride topical gels. Bull Pharm Sci Assiut 28(2):283\u2013289. https:\/\/doi.org\/10.21608\/bfsa.2005.65405","journal-title":"Bull Pharm Sci Assiut"},{"issue":"3","key":"4294_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.9734\/BJPR\/2014\/2775","volume":"3","author":"A Mekkawy","year":"2013","unstructured":"Mekkawy A, Fathy M, El-Shanawany S (2013) Formulation and in vitro evaluation of fluconazole topical gels. Br J Pharm Res 3(3):293\u2013313. https:\/\/doi.org\/10.9734\/BJPR\/2014\/2775","journal-title":"Br J Pharm Res"},{"issue":"3","key":"4294_CR18","doi-asserted-by":"publisher","first-page":"008","DOI":"10.7324\/JAPS.2016.60302","volume":"6","author":"MH El Nagar","year":"2016","unstructured":"El Nagar MH, Mahdy M, Selem M, El Maghraby G (2016) Transdermal delivery of Kojic acid from microemulgel. J Appl Pharm Sci 6(3):008\u201316. https:\/\/doi.org\/10.7324\/JAPS.2016.60302","journal-title":"J Appl Pharm Sci"},{"issue":"4","key":"4294_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/pharmaceutics13040444","volume":"13","author":"A Mahran","year":"2021","unstructured":"Mahran A, Ismail S, Allam AA (2021) Development of triamcinolone acetonide-loaded microemulsion as a prospective ophthalmic delivery system for treatment of uveitis: in vitro and in vivo evaluation. Pharmaceutics 13(4):444. https:\/\/doi.org\/10.3390\/pharmaceutics13040444","journal-title":"Pharmaceutics"},{"key":"4294_CR20","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.3390\/pharmaceutics15010022","volume":"15","author":"AA Abdellatif","year":"2022","unstructured":"Abdellatif AA, Aldosari BN, Al-Subaiyel A, Alhaddad A, Samman WA, Eleraky NE et al (2022) Transethosomal gel for the topical delivery of celecoxib: formulation and Estimation of skin Cancer progression. Pharmaceutics 15:e22. https:\/\/doi.org\/10.3390\/pharmaceutics15010022","journal-title":"Pharmaceutics"},{"issue":"12","key":"4294_CR21","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1111\/jocd.14440","volume":"20","author":"MS Zaky","year":"2021","unstructured":"Zaky MS, Obaid ZM, Khalil EA, Elsaie ML (2021) Microneedling-assisted topical Tranexamic acid solution versus 4% hydroquinone for treating melasma: A split-face randomized study. J Cosmet Dermatol 20(12):4011\u20134016. https:\/\/doi.org\/10.1111\/jocd.14440","journal-title":"J Cosmet Dermatol"},{"key":"4294_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4236\/jcdsa.2014.42014","volume":"4","author":"X Wang","year":"2014","unstructured":"Wang X, Li Z, Zhang D, Li L, Sophie S (2014) A double-blind, placebo controlled clinical trial evaluating the efficacy and safety of a new skin whitening combination in patients with Chloasma. J Cosmet Dermatol Sci Appl 4:92\u201398. https:\/\/doi.org\/10.4236\/jcdsa.2014.42014","journal-title":"J Cosmet Dermatol Sci Appl"},{"key":"4294_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/CCID.S147413","volume":"11","author":"AM Badawi","year":"2018","unstructured":"Badawi AM, Osman MA (2018) Fractional erbium-doped yttrium aluminum Garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. Clin Cosmet Investig Dermatol 11:13\u201320. https:\/\/doi.org\/10.2147\/CCID.S147413","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"4294_CR24","doi-asserted-by":"publisher","first-page":"e13629","DOI":"10.1111\/dth.13629","volume":"33","author":"R Abdel Hay","year":"2020","unstructured":"Abdel Hay R, Mohammed FN, Sayed KS, Abd El Fattah NA, Ibrahim S (2020) Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser. Dermatol Ther 33(4):e13629. https:\/\/doi.org\/10.1111\/dth.13629","journal-title":"Dermatol Ther"},{"issue":"1","key":"4294_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12032-016-0865-2","volume":"34","author":"M Kato","year":"2016","unstructured":"Kato M, Nishihara H, Hayashi H, Kimura T, Ishida Y, Wang L et al (2016) Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma. Med Oncol 34(1):8. https:\/\/doi.org\/10.1007\/s12032-016-0865-2","journal-title":"Med Oncol"},{"issue":"11","key":"4294_CR26","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1111\/jocd.14382","volume":"20","author":"O Artzi","year":"2021","unstructured":"Artzi O, Horovitz T, Bar-Ilan E, Shehadeh W, Koren A, Zusmanovitch L et al (2021) The pathogenesis of melasma and implications for treatment. J Cosmet Dermatol 20(11):3432\u20133445. https:\/\/doi.org\/10.1111\/jocd.14382","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"4294_CR27","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1111\/jocd.15242","volume":"21","author":"VK Mahajan","year":"2022","unstructured":"Mahajan VK, Patil A, Blicharz L, Kassir M, Konnikov N, Gold MH et al (2022) Medical therapies for melasma. J Cosmet Dermatol 21(9):3707\u20133728. https:\/\/doi.org\/10.1111\/jocd.15242","journal-title":"J Cosmet Dermatol"},{"key":"4294_CR28","doi-asserted-by":"publisher","unstructured":"Singh S, Sharma N, Zahoor I, Behl T, Antil A, Gupta S et al (2022) Potential of Nanotechnology-Based Approaches as Cutting-Edge for Management of Hyperpigmentation Disorder. Molecules;28(1):220. https:\/\/doi.org\/10.3390\/molecules28010220","DOI":"10.3390\/molecules28010220"},{"issue":"3","key":"4294_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5021\/ad.2015.27.3.250","volume":"27","author":"MS Kim","year":"2015","unstructured":"Kim MS, Bang SH, Kim J-H, Shin H-J, Choi J-H, Chang SE (2015) Tranexamic acid diminishes laser-induced melanogenesis. Ann Dermatol 27(3):250\u2013256. https:\/\/doi.org\/10.5021\/ad.2015.27.3.250","journal-title":"Ann Dermatol"},{"issue":"2","key":"4294_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/156720106776359168","volume":"3","author":"P Ghosh","year":"2006","unstructured":"Ghosh P, Murthy R (2006) Microemulsions: a potential drug delivery system. Curr Drug Deliv 3(2):167\u2013180. https:\/\/doi.org\/10.2174\/156720106776359168","journal-title":"Curr Drug Deliv"},{"key":"4294_CR31","doi-asserted-by":"publisher","first-page":"101984","DOI":"10.1016\/j.jddst.2020.101984","volume":"60","author":"S Hatem","year":"2020","unstructured":"Hatem S, El Hoffy NM, Elezaby RS, Nasr M, Kamel AO, Elkheshen SA (2020) Background and different treatment modalities for melasma: conventional and nanotechnology-based approaches. J Drug Deliv Sci Technol 60:101984. https:\/\/doi.org\/10.1016\/j.jddst.2020.101984","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"4294_CR32","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/jocd.13537","volume":"20","author":"KMM Mekawy","year":"2021","unstructured":"Mekawy KMM, Sadek A, Seddeik Abdel-Hameed AK (2021) Micro-needling versus fractional carbon dioxide laser for delivery of Tranexamic acid in the treatment of melasma: A split-face study. J Cosmet Dermatol 20(2):460\u2013465. https:\/\/doi.org\/10.1111\/jocd.13537","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"4294_CR33","doi-asserted-by":"publisher","first-page":"e2023195","DOI":"10.5826\/dpc.1303a195","volume":"13","author":"SMK Dawaud","year":"2023","unstructured":"Dawaud SMK, Hegab DS, El Maghraby GM, El-Ashmawy AA (2023) Efficacy and safety of topical Tranexamic acid alone or in combination with either fractional carbon dioxide laser or microneedling for the treatment of melasma. Dermatol Pract Concept 13(3):e2023195. https:\/\/doi.org\/10.5826\/dpc.1303a195","journal-title":"Dermatol Pract Concept"},{"issue":"1","key":"4294_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10103-023-03810-5","volume":"38","author":"QA Khan","year":"2023","unstructured":"Khan QA, Abdi P, Farkouh C, Anthony MR, Chundru A, Amatul F et al (2023) Effectiveness of laser and topical Tranexamic acid combination therapy in melasma: an updated systematic review and meta-analysis of randomized controlled trials. Lasers Med Sci 38(1):139. https:\/\/doi.org\/10.1007\/s10103-023-03810-5","journal-title":"Lasers Med Sci"},{"issue":"1","key":"4294_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.21608\/bjas.2018.188891","volume":"3","author":"H Sabry","year":"2018","unstructured":"Sabry H, Salemand R, Elkholy A (2018) Fractional CO2 laser assisted delivery of topical Tranexamic acid in treatment of melasma. Benha J Appl Sci 3(1):73\u201376. https:\/\/doi.org\/10.21608\/bjas.2018.188891","journal-title":"Benha J Appl Sci"},{"issue":"3","key":"4294_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jocd.12152","volume":"14","author":"M Banihashemi","year":"2015","unstructured":"Banihashemi M, Zabolinejad N, Jaafari MR, Salehi M, Jabari A (2015) Comparison of therapeutic effects of liposomal Tranexamic acid and conventional hydroquinone on melasma. J Cosmet Dermatol 14(3):174\u2013177. https:\/\/doi.org\/10.1111\/jocd.12152","journal-title":"J Cosmet Dermatol"},{"issue":"12","key":"4294_CR37","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1111\/jocd.13810","volume":"19","author":"X Xing","year":"2020","unstructured":"Xing X, Chen L, Xu Z, Jin S, Zhang C, Xiang L (2020) The efficacy and safety of topical Tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma. J Cosmet Dermatol 19(12):3238\u20133244. https:\/\/doi.org\/10.1111\/jocd.13810","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"4294_CR38","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1080\/09546634.2020.1781755","volume":"33","author":"MM Gamea","year":"2022","unstructured":"Gamea MM, Kamal DA, Donia AA, Hegab DS (2022) Comparative study between topical Tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma. J Dermatol Treat 33(2):798\u2013804. https:\/\/doi.org\/10.1080\/09546634.2020.1781755","journal-title":"J Dermatol Treat"},{"issue":"1","key":"4294_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/idoj.IDOJ_22_19","volume":"11","author":"A Menon","year":"2020","unstructured":"Menon A, Eram H, Kamath PR, Goel S, Babu AM (2020) A split face comparative study of safety and efficacy of microneedling with Tranexamic acid versus microneedling with vitamin C in the treatment of melasma. Indian Dermatol Online J 11(1):41\u201345. https:\/\/doi.org\/10.4103\/idoj.IDOJ_22_19","journal-title":"Indian Dermatol Online J"},{"issue":"7","key":"4294_CR40","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1111\/jocd.14538","volume":"21","author":"Y El Attar","year":"2022","unstructured":"El Attar Y, Doghaim N, El Far N, El hedody S, Hawwam Soha A (2022) Efficacy and safety of Tranexamic acid versus vitamin C after microneedling in treatment of melasma: clinical and dermoscopic study. J Cosmet Dermatol 21(7):2817\u20132825. https:\/\/doi.org\/10.1111\/jocd.14538","journal-title":"J Cosmet Dermatol"},{"issue":"11","key":"4294_CR41","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1097\/DSS.0000000000002449","volume":"46","author":"HM Ebrahim","year":"2020","unstructured":"Ebrahim HM, Said Abdelshafy A, Khattab F, Gharib K (2020) Tranexamic acid for melasma treatment: A Split-Face study. Dermatol Surg 46(11):e102\u2013e7. https:\/\/doi.org\/10.1097\/DSS.0000000000002449","journal-title":"Dermatol Surg"},{"issue":"4","key":"4294_CR42","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/jocd.13992","volume":"20","author":"Y Qu","year":"2021","unstructured":"Qu Y, Wang F, Liu J, Xia X (2021) Clinical observation and dermoscopy evaluation of fractional CO2 laser combined with topical Tranexamic acid in melasma treatments. J Cosmet Dermatol 20(4):1110\u20131116. https:\/\/doi.org\/10.1111\/jocd.13992","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"4294_CR43","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1080\/09546634.2021.1871582","volume":"33","author":"AI Tahoun","year":"2022","unstructured":"Tahoun AI, Mostafa WZ, Amer MA (2022) Dermoscopic evaluation of Tranexamic acid versus vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study. J Dermatol Treat 33(3):1623\u20131629. https:\/\/doi.org\/10.1080\/09546634.2021.1871582","journal-title":"J Dermatol Treat"},{"issue":"4","key":"4294_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.joto.2022.08.003","volume":"17","author":"J Qi","year":"2022","unstructured":"Qi J, Ma L, Guo W (2022) Recent advances in the regulation mechanism of SOX10. J Otol 17(4):247\u2013. https:\/\/doi.org\/10.1016\/j.joto.2022.08.003. \u200952","journal-title":"J Otol"},{"issue":"2","key":"4294_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2230.2012.04473.x","volume":"38","author":"JE Kim","year":"2013","unstructured":"Kim JE, Chang SE, Yeo UC, Haw S, Kim IH (2013) Histopathological study of the treatment of melasma lesions using a low-fluence Q\u2010switched 1064\u2010nm neodymium:yttrium\u2013aluminium\u2013garnet laser. Clin Exp Dermatol 38(2):167\u2013171. https:\/\/doi.org\/10.1111\/j.1365-2230.2012.04473.x","journal-title":"Clin Exp Dermatol"},{"key":"4294_CR46","doi-asserted-by":"publisher","unstructured":"Olugbade ID, Negbenebor NA (2024) The use of Tranexamic acid and microneedling in the treatment of melasma: A systematic review. Cutis 114(2):E15\u2013E23. https:\/\/doi.org\/10.12788\/cutis.1080","DOI":"10.12788\/cutis.1080"},{"issue":"5","key":"4294_CR47","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/jocd.14836","volume":"21","author":"A Sadeghzadeh-Bazargan","year":"2022","unstructured":"Sadeghzadeh-Bazargan A, Behrangi E, Najar Nobari N, Ghassemi M, Roohaninasab M, Goodarzi A (2022) Systematic review of clinical studies assessing the needling for treatment of melasma: focusing on efficacy, safety, and recurrence rate. J Cosmet Dermatol 21(5):1857\u20131873. https:\/\/doi.org\/10.1111\/jocd.14836","journal-title":"J Cosmet Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04294-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T06:38:06Z","timestamp":1748846286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04294-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4294"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04294-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants followed the ethical standards of the institutional and\/or national research committee, as well as the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All patients were informed about the study procedure, benefits, and potential complications, and informed consent was obtained from each patient. The study protocol was approved by the Ethics Committee, Faculty of Medicine, Assiut University, Egypt (IRB17200535).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consents were obtained from the patients to publish their photos.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"792"}}